Treatment with perilesional injections of pentoxifylline in patients with Peyronie's disease improves the therapeutic effect of oral and topical antioxidant therapy
To the Editor, We conducted a retrospective study to demonstrate that it is possible to achieve better therapeutic outcomes through combining perilesional injections of pentoxifylline (PTX) with oral antioxidants and the local application of a cream containing antioxidants and a gel containing dicl...
Saved in:
Main Authors: | Gianni Paulis, Andrea Paulis, Giovanni De Giorgio |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2025-02-01
|
Series: | Archivio Italiano di Urologia e Andrologia |
Subjects: | |
Online Access: | https://www.pagepressjournals.org/aiua/article/view/13525 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Pathophysiological Aspects of Peyronie’s Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment—Literature Review
by: Gianni Paulis, et al.
Published: (2017-01-01) -
Injectable agents for the induction of Peyronie’s disease in model rats: a comparative study
by: Guang-Jun Du, et al.
Published: (2025-01-01) -
Pentoxifylline Prevents Autoimmune MediatedInflammation in Low Dose Streptozotocin InducedDiabetes
by: Stanislava D. Stošić-Grujičić, et al.
Published: (2001-01-01) -
Effects of L-carnitine and pentoxifylline on long-term preservation of the human sperms: An experimental study
by: Elham Aliabadi, et al.
Published: (2025-01-01) -
Treatment with Autologous Adipose-derived Regenerative Cells for Peyronie’s Disease in Men: The Straight @head Pilot Study
by: Majken H. Wiborg, et al.
Published: (2025-01-01)